Article
CYP2C9 promoter variable number tandem repeat polymorphism regulates mRNA expression in human livers.
Drug metabolism and disposition: the biological fate of chemicals - 1 May 2012
Wang Danxin, Sun Xiaochun, Gong Yan, Gawronski Brian E, Langaee Taimour Y, Shahin Mohamed Hossam A, Khalifa Sherief I, Johnson Julie A
Abstract excerpt
CYP2C9 is involved in metabolism of nearly 25% of clinically used drugs. Coding region polymorphisms CYP2C9*2 and *3 contribute to interperson variability in drug dosage and clinical outcomes, whereas the role of a regulatory polymorphism remains uncertain. Measuring allelic RNA expression in 87 human liver samples, combined with genotyping, sequencing, and reporter gene assays, we identified a promoter variable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
